Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid strategy comparison in total knee arthroplasty
ChiCTR2000030624Phase 4Recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in knee osteoarthritis (OA) (5 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Blood loss, Blood transfusion rate and 3 more. Started May 2020; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2000030624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030624.